Literature DB >> 2150815

Prevalence of Staphylococcus aureus and coagulase-negative staphylococci with decreased sensitivity to glycopeptides as assessed by determination of MICs.

G Vedel1, M Leruez, F Lémann, E Hraoui, D Ratovohery.   

Abstract

The prevalence of staphylococci with decreased sensitivity to glycopeptides was assessed at a Paris hospital by determination of the MICs. The values obtained using the MIC method were compared to those obtained using the routine disk agar diffusion method. One hundred independently isolated strains were tested including 57 Staphylococcus aureus isolates and 43 coagulase-negative staphylococci (CNS). For all strains vancomycin MICs were less than or equal to 4 mg/l but for 5.3% of the Staphylococcus aureus isolates and 25.6% of the CNS isolates teicoplanin MICs were high (greater than or equal to 8 mg/l). Moreover, teicoplanin MICs did not correlate well with zone sizes. The MIC method is therefore recommended for evaluating the susceptibility of staphylococci to teicoplanin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2150815     DOI: 10.1007/bf01967381

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  6 in total

1.  In-vitro selection of resistance of Staphylococcus aureus to teicoplanin and vancomycin.

Authors:  C Watanakunakorn
Journal:  J Antimicrob Chemother       Date:  1990-01       Impact factor: 5.790

2.  Failure of teicoplanin therapy in two neutropenic patients with staphylococcal septicemia who recovered after administration of vancomycin.

Authors:  F Brunet; G Vedel; F Dreyfus; J F Vaxelaire; T Giraud; B Schremmer; J F Monsallier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-02       Impact factor: 3.267

3.  In-vitro teicoplanin-resistance in coagulase-negative staphylococci from patients with endocarditis and from a cardiac surgery unit.

Authors:  E P Moore; D C Speller
Journal:  J Antimicrob Chemother       Date:  1988-04       Impact factor: 5.790

4.  In-vitro induction of resistance in coagulase-negative staphylococci to vancomycin and teicoplanin.

Authors:  C Watanakunakorn
Journal:  J Antimicrob Chemother       Date:  1988-09       Impact factor: 5.790

Review 5.  Mode of action and in-vitro activity of vancomycin.

Authors:  C Watanakunakorn
Journal:  J Antimicrob Chemother       Date:  1984-12       Impact factor: 5.790

6.  Early termination of a prospective, randomized trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections.

Authors:  P Calain; K H Krause; P Vaudaux; R Auckenthaler; D Lew; F Waldvogel; B Hirschel
Journal:  J Infect Dis       Date:  1987-02       Impact factor: 5.226

  6 in total
  3 in total

Review 1.  Current perspectives on glycopeptide resistance.

Authors:  N Woodford; A P Johnson; D Morrison; D C Speller
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

2.  Activity of glycopeptides against Staphylococcus aureus infection in a rabbit endocarditis model: MICs do not predict in vivo efficacy.

Authors:  Nathalie Asseray; Cedric Jacqueline; Virginie Le Mabecque; Eric Batard; Denis Bugnon; Gilles Potel; Jocelyne Caillon
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

3.  Emergence of teicoplanin-resistant coagulase-negative staphylococci.

Authors:  E Cercenado; M E García-Leoni; M D Díaz; C Sánchez-Carrillo; P Catalán; J C De Quirós; E Bouza
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.